Comparison of Humira biosimilars in the US and Europe
The US biosimilars market is notably underdeveloped and biosimilar entry in the US has been difficult, consistently lagging behind Europe.
Vertex signs licence deal with CRISPR Therapeutics for diabetes therapies
MHRA revamps UK clinical trial regulation with the promise of faster timelines
Race for a first-to-market therapy for NASH heats up
Tapping into digital therapeutics to improve neurological outcomes
Risk sharing agreements soar as market access risk increases
Analysis
View More
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Themes
View MoreChina’s NMPA grants EUA to CSPC Pharmaceutical’s Covid-19 vaccine
CSPC Pharmaceutical’s SYS6006 has been designed to target some major Omicron variants.
More themes
Insights
View MoreMerck reports rise in group net sales in fiscal 2022
The company reported an organic sales increase of 8.2% to €10.38bn in its Life Science business during the year.
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Risk of venous thromboembolism in Covid-19 outpatients found to be low
InvisiShield and Gladstone partner to develop intranasal preventatives
Talem and Libera Bio partner for discovery of AI-driven antibodies
One Medical CEO rebuts Amazon data privacy concerns